Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT).
Albiero R, Silber S, Di Mario C, Cernigliaro C, Battaglia S, Reimers B, Frasheri A, Klauss V, Auge JM, Rubartelli P, Morice MC, Cremonesi A, Schofer J, Bortone A, Colombo A; RESCUT Investigators. Albiero R, et al. Among authors: frasheri a. J Am Coll Cardiol. 2004 Mar 17;43(6):943-9. doi: 10.1016/j.jacc.2003.09.054. J Am Coll Cardiol. 2004. PMID: 15028348 Free article. Clinical Trial.
Family history, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: A one-year follow-up study.
Rizzo M, Barbagallo CM, Noto D, Pace A, Cefalú AB, Pernice V, Pinto V, Rubino A, Pieri D, Traina M, Frasheri A, Notarbartolo A, Averna MR. Rizzo M, et al. Among authors: frasheri a. Nutr Metab Cardiovasc Dis. 2005 Oct;15(5):361-7. doi: 10.1016/j.numecd.2005.02.004. Epub 2005 Jul 1. Nutr Metab Cardiovasc Dis. 2005. PMID: 16216722
LDL size and subclasses in patients with abdominal aortic aneurysm.
Rizzo M, Krayenbühl PA, Pernice V, Frasheri A, Battista Rini G, Berneis K. Rizzo M, et al. Among authors: frasheri a. Int J Cardiol. 2009 May 29;134(3):406-8. doi: 10.1016/j.ijcard.2007.12.082. Epub 2008 Mar 25. Int J Cardiol. 2009. PMID: 18367268 Free article.
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial.
Colombo A, Chieffo A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N, Oteo Dominguez JF, Steffanon L, Tarantini G, Presbitero P, Menozzi A, Pucci E, Mauri J, Cesana BM, Giustino G, Sardella G. Colombo A, et al. Among authors: frasheri a. J Am Coll Cardiol. 2014 Nov 18-25;64(20):2086-97. doi: 10.1016/j.jacc.2014.09.008. Epub 2014 Sep 15. J Am Coll Cardiol. 2014. PMID: 25236346 Free article. Clinical Trial.
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy.
Tarantini G, Nai Fovino L, Tellaroli P, Chieffo A, Barioli A, Menozzi A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N, Dominguez JF, Steffanon L, Presbitero P, Pucci E, Fraccaro C, Mauri J, Giustino G, Sardella G, Colombo A. Tarantini G, et al. Among authors: frasheri a. Int J Cardiol. 2016 Mar 15;207:168-76. doi: 10.1016/j.ijcard.2016.01.068. Epub 2016 Jan 11. Int J Cardiol. 2016. PMID: 26803236 Clinical Trial.
21 results